MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Clinical trial NCT00703690 · TERMINATED

Trial details

NCT number: NCT00703690
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic X Syndrome Dyslipidemia

Start date: 2002-01-01
Primary completion: 2003-12-01
Enrollment: 436

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.